0001437749-22-023060.txt : 20220926 0001437749-22-023060.hdr.sgml : 20220926 20220926160745 ACCESSION NUMBER: 0001437749-22-023060 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220923 FILED AS OF DATE: 20220926 DATE AS OF CHANGE: 20220926 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ROGERS MICHAEL W CENTRAL INDEX KEY: 0001244159 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36361 FILM NUMBER: 221265758 MAIL ADDRESS: STREET 1: C/O KERYX BIOPHARMACEUTICALS INC STREET 2: ONE MARINA PARK DRIVE CITY: BOSTON STATE: MA ZIP: 02210 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aravive, Inc. CENTRAL INDEX KEY: 0001513818 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 264106690 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: RIVER OAKS TOWER STREET 2: 3730 KIRBY DRIVE, SUITE 1200 CITY: HOUSTON STATE: TX ZIP: 77098 BUSINESS PHONE: 936-355-1910 MAIL ADDRESS: STREET 1: RIVER OAKS TOWER STREET 2: 3730 KIRBY DRIVE, SUITE 1200 CITY: HOUSTON STATE: TX ZIP: 77098 FORMER COMPANY: FORMER CONFORMED NAME: Versartis, Inc. DATE OF NAME CHANGE: 20110223 4 1 rdgdoc.xml FORM 4 X0306 4 2022-09-23 0001513818 Aravive, Inc. ARAV 0001244159 ROGERS MICHAEL W C/O ARAVIVE, INC., RIVER OAKS TOWER, 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098 1 Stock Option (Right to Buy) 0.9152 2022-09-23 4 A 0 97063 0 A 2022-10-23 2032-09-22 Common Stock 97063 97063 D These options vest pro rata on a monthly basis commencing on October 23,2022 for the next 12 months with full vesting, if not fully vested at such time, on the date of Aravive, Inc.'s next annual meeting of stockholders. /s/ Abel Svitavsky, Attorney-In-Fact 2022-09-26